Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-17 01:09 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $495.36 | 3,517 | $1,742,193 | 8,142 |
| 2025-12-17 00:30 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | PATUSKY CHRISTOPHER | Director | OPT+S | $495.95 | 1,000 | $495,954 | 1,490 |
| 2025-12-17 01:08 | 2025-12-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $494.09 | 8,000 | $3,952,689 | 130 |
| 2025-12-17 00:29 | 2025-12-16 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | Officer | OPT+S | $61.24 | 2,200 | $134,728 | 138,552 |
| 2025-12-16 01:39 | 2025-12-12 | EQ | Equillium, Inc. | Zedelmayer Christine | Officer | SELL | $1.33 | 35,704 | $47,486 | 91,444 |
| 2025-12-16 00:43 | 2025-12-11 | ELAN | Elanco Animal Health Inc | Modi Rajeev A. | Officer | BUY | $21.33 | 4,500 | $95,985 | 123,082 |
| 2025-12-16 00:42 | 2025-12-11 | ELAN | Elanco Animal Health Inc | VanHimbergen Robert M | Officer | BUY | $21.64 | 6,950 | $150,426 | 124,233 |
| 2025-12-16 00:30 | 2025-12-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | Officer | OPT+S | $111.00 | 3,350 | $371,850 | 20,814 |
| 2025-12-16 05:34 | 2025-12-11 | ROIV | Roivant Sciences Ltd. | Ramaswamy Vivek | 10% owner | OPT+S | $21.89 | 3,103,745 | $67,942,220 | 34,132,463 |
| 2025-12-16 01:24 | 2025-12-12 | XERS | Xeris Biopharma Holdings, Inc. | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | SELL | $7.09 | 15,000 | $106,415 | 142,500 |
| 2025-12-16 01:49 | 2025-12-11 | IRON | Disc Medicine, Inc. | Quisel John D | Director, Officer | OPT+S | $93.05 | 40,000 | $3,721,932 | 171,828 |
| 2025-12-16 00:18 | 2025-12-11 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Cormorant Asset Management, LP | 10% owner | SELL | $11.46 | 30,029 | $344,012 | 2,344,971 |
| 2025-12-16 03:34 | 2025-12-15 | RZLT | Rezolute, Inc. | Karnawat Sunil Ratilal | Officer | BUY | $1.62 | 12,100 | $19,598 | 71,542 |
| 2025-12-16 00:41 | 2025-12-11 | ELAN | Elanco Animal Health Inc | Simmons Jeffrey N | Director, Officer | BUY | $21.75 | 22,000 | $478,496 | 167,000 |
| 2025-12-16 00:15 | 2025-12-11 | BMEA | Biomea Fusion, Inc. | Erdtmann Rainer M | Director, Officer | BUY | $1.43 | 30,000 | $42,999 | 723,027 |
| 2025-12-16 03:35 | 2025-12-15 | RZLT | Rezolute, Inc. | Evans Daron | Officer | BUY | $1.77 | 45,000 | $79,578 | 7,000 |
| 2025-12-16 01:24 | 2025-12-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | Matrix Capital Management Company, LP | 10% owner | SELL | $1.33 | 7,500,000 | $9,975,000 | 6,459,973 |
| 2025-12-16 03:55 | 2025-12-11 | CLYM | Climb Bio, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $2.40 | 314,561 | $754,726 | 3,396,318 |
| 2025-12-16 03:35 | 2025-12-15 | RZLT | Rezolute, Inc. | Elam Nevan C | Director, Officer | BUY | $1.59 | 32,000 | $50,880 | 641,119 |
| 2025-12-16 01:17 | 2025-12-11 | AMPH | Amphastar Pharmaceuticals Inc. | Petersen Floyd F. | Director | SELL | $25.82 | 4,163 | $107,508 | 71,368 |
| 2025-12-16 04:07 | 2025-12-11 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director | BUY | $42.50 | 5,882 | $249,985 | 5,882 |
| 2025-12-16 00:38 | 2025-12-12 | OGEN | ORAGENICS INC | Telling Fred | Director | SELL | $0.94 | 210 | $198 | 34,538 |
| 2025-12-16 00:32 | 2025-12-11 | WVE | Wave Life Sciences Ltd. | GSK plc | 10% owner | BUY | $19.00 | 1,470,000 | $27,930,000 | 18,245,691 |
| 2025-12-16 00:51 | 2025-12-11 | PAHC | PHIBRO ANIMAL HEALTH CORP | BENDHEIM JACK | Director, Officer, 10% owner | SELL | $40.93 | 5,752 | $235,405 | 39,200 |
| 2025-12-13 02:00 | 2025-12-12 | TTRX | Turn Therapeutics Inc. | Chaudhary Zuraiz | Officer | BUY | $3.50 | 2,500 | $8,750 | 12,500 |
| 2025-12-12 15:16 | 2025-12-11 | FBLG | FibroBiologics, Inc. | GARCIA RUBEN A | Officer | BUY | $0.34 | 140,000 | $47,600 | 140,000 |
| 2025-12-12 16:39 | 2025-12-10 | SXTP | 60 DEGREES PHARMACEUTICALS, INC. | DOW GEOFFREY S | Director, Officer | BUY | $0.94 | 12,963 | $12,205 | 49,948 |
| 2025-12-13 04:30 | 2025-12-11 | AARD | Aardvark Therapeutics, Inc. | Sun Nelson | Officer | BUY | $14.40 | 3,000 | $43,200 | 108,484 |
| 2025-12-13 04:30 | 2025-12-11 | AARD | Aardvark Therapeutics, Inc. | Lee Tien-Li | Director, Officer, 10% owner | BUY | $14.49 | 7,000 | $101,395 | 1,551,613 |
| 2025-12-13 00:56 | 2025-12-10 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | Officer | OPT+S | $321.64 | 664 | $213,569 | 0 |
| 2025-12-13 01:06 | 2025-12-10 | VSTM | Verastem, Inc. | Paterson Dan | Director, Officer | SELL | $10.04 | 4,000 | $40,140 | 410,818 |
| 2025-12-12 20:48 | 2025-12-11 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer | OPT+S | $3.24 | 3,555 | $11,520 | 0 |
| 2025-12-13 00:40 | 2025-12-10 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | FRIEDMAN PAUL A | Director | OPT+S | $552.18 | 24,800 | $13,694,158 | 187,164 |
| 2025-12-13 00:35 | 2025-12-10 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Director | OPT+S | $552.15 | 18,650 | $10,297,573 | 461,044 |
| 2025-12-13 01:32 | 2025-12-10 | HOWL | Werewolf Therapeutics, Inc. | EVNIN LUKE | Director | SELL | $1.07 | 82,971 | $88,588 | 2,890,128 |
| 2025-12-13 01:30 | 2025-12-10 | CYRX | Cryoport, Inc. | Mandalam Ramkumar | Director | SELL | $9.99 | 11,570 | $115,540 | 80,758 |
| 2025-12-13 00:32 | 2025-12-11 | UTHR | UNITED THERAPEUTICS Corp | MALCOLM JAN | Director | SELL | $482.98 | 50 | $24,149 | 470 |
| 2025-12-13 00:32 | 2025-12-11 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | Officer | OPT+S | $484.67 | 11,000 | $5,331,316 | 36,781 |
| 2025-12-13 00:31 | 2025-12-11 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $487.33 | 8,000 | $3,898,662 | 130 |
| 2025-12-13 00:26 | 2025-12-12 | ANIP | Ani Pharmaceuticals Inc. | Cook Meredith | Officer | SELL | $82.32 | 400 | $32,928 | 74,874 |
| 2025-12-11 16:31 | 2025-12-10 | APRE | Clear Creek Independent School District | Duey Marc | Director | BUY | $1.17 | 21,459 | $25,000 | 256,155 |
| 2025-12-12 00:09 | 2025-12-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Daniell Richard | Officer | OPT+S | $28.68 | 115,468 | $3,311,126 | 48,384 |
| 2025-12-12 00:06 | 2025-12-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | Officer | OPT+S | $28.73 | 216,892 | $6,230,765 | 52,828 |
| 2025-12-11 16:31 | 2025-12-10 | APRE | Clear Creek Independent School District | Hamill John P. | Officer | BUY | $1.17 | 5,000 | $5,825 | 27,733 |
| 2025-12-12 05:00 | 2025-12-09 | ROIV | Roivant Sciences Ltd. | Venker Eric | Officer | OPT+S | $20.85 | 200,000 | $4,170,000 | 1,497,908 |
| 2025-12-11 20:10 | 2025-12-10 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Officer | SELL | $36.38 | 3,081 | $112,087 | 95,146 |
| 2025-12-11 16:38 | 2025-12-09 | CRMD | CorMedix Inc. | Dillione Janet | Director | OPT+S | $12.00 | 34,000 | $408,000 | 48,473 |
| 2025-12-12 05:47 | 2025-12-09 | PCRX | Pacira BioSciences, Inc. | Cross Shawn | Officer | OPT+S | $25.07 | 25,000 | $626,753 | 56,250 |
| 2025-12-12 00:11 | 2025-12-09 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer | OPT+S | $3.33 | 1,245 | $4,149 | 0 |
| 2025-12-12 01:19 | 2025-12-09 | JAZZ | Jazz Pharmaceuticals plc | Henderson Mary Elizabeth | Officer | SELL | $169.51 | 2,238 | $379,366 | 19,508 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.